- Mar 30, 2021
Protein Target for Neuroblastoma
Australian researchers have discovered a new way to target an aggressive childhood cancer, neuroblastoma, one of the most common and dangerous cancers in young children. Read more: https://www.technologynetworks.com/drug-discovery/news/team-pinpoints-therapeutic-protein-target-for-neuroblastoma-347128
- Mar 26, 2021
Pediatric cancers have unique genetic vulnerabilities
Most cancer drugs that target specific genetic mutations are designed for adult cancers rather than those in children, partly because pediatric cancers have fewer mutations. To look for more ways to target childhood cancers, researchers at the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and Boston Children's Hospital decided to look for genetic dependencies in various pediatric cancers. Read more: https://medicalxpress.com/news/2021-03-pediatric-canc
- Mar 19, 2021
ATRT molecular groups: looking at the biology from the clinic
Atypical teratoid rhabdoid tumor (ATRT) is a rare brain tumor that predominantly occurs in young children. Scientists at St. Jude Children’s Research Hospital used data from two clinical trials to study the molecular groups of ATRT and correlate them with clinical outcomes. Read more: https://www.newswise.com/articles/atrt-molecular-groups-looking-at-the-biology-from-the-clinic
- Mar 18, 2021
Pediatric Cancer Survivors and Diabetes: What Are the Risks?
Diabetes and metabolic syndrome represent two of the most common long-term complications for survivors of childhood cancer. Approximately 50% of cancer survivors will be diagnosed with at least 1 hormonal abnormality during their lifetime. Read more: https://www.cancertherapyadvisor.com/home/cancer-topics/pediatric-cancer/pediatric-cancer-patients-diabetes-metabolic-syndrome-lifestyle-change/
- Mar 15, 2021
COVID-19 Impacting Caregivers of Children With Cancer
Caregivers of childhood cancer survivors are experiencing changes to medical care, financial disruptions, and emotional distress due to COVID-19, according to a study published in the April issue of Pediatric Blood & Cancer. Read more: https://consumer.healthday.com/covid-19-impacting-caregivers-of-child-cancer-survivors-2650883473.html
- Mar 12, 2021
Natural "brake" against malignant neuroblastoma
The scientists discovered that the uncontrolled growth of benign neuroblastomas is stopped by a signal molecule produced by Schwann cells present within these tumors. Read more: https://www.eurekalert.org/pub_releases/2021-03/sacc-na031121.php
- Mar 3, 2021
Origin of childhood cancer malignant rhabdoid tumour discovered
The first proof of the origin of malignant rhabdoid tumour (MRT), a rare childhood cancer, has been discovered by researchers at the Wellcome Sanger Institute, the Princess Máxima Center for Pediatric Oncology in the Netherlands, and their collaborators. Read more: https://www.eurekalert.org/pub_releases/2021-03/wtsi-ooc030221.php